Stryker Dirección

Dirección controles de criterios 3/4

El CEO de Stryker's es Kevin Lobo , nombrado en Oct 2012, tiene una permanencia de 11.83 años. compensación anual total es $20.77M, compuesta por 6.7% salario y 93.3% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.026% de las acciones de la empresa, por valor de R$185.83M. La antigüedad media del equipo directivo y de la junta directiva es de 6 años y 6.3 años, respectivamente.

Información clave

Kevin Lobo

Chief Executive Officer (CEO)

US$20.8m

Compensación total

Porcentaje del salario del CEO	6.7%
Permanencia del CEO	11.9yrs
Participación del CEO	0.03%
Permanencia media de la dirección	6yrs
Promedio de permanencia en la Junta Directiva	6.3yrs

Actualizaciones recientes de la dirección

Recent updates

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Kevin Lobo en comparación con los beneficios de Stryker?
Fecha	Compensación total	Salario	Ingresos de la empresa
Jun 30 2024	n/a	n/a	US$3b
Mar 31 2024	n/a	n/a	US$3b
Dec 31 2023	US$21m	US$1m	US$3b
Sep 30 2023	n/a	n/a	US$3b
Jun 30 2023	n/a	n/a	US$3b
Mar 31 2023	n/a	n/a	US$3b
Dec 31 2022	US$19m	US$1m	US$2b
Sep 30 2022	n/a	n/a	US$2b
Jun 30 2022	n/a	n/a	US$2b
Mar 31 2022	n/a	n/a	US$2b
Dec 31 2021	US$16m	US$1m	US$2b
Sep 30 2021	n/a	n/a	US$2b
Jun 30 2021	n/a	n/a	US$2b
Mar 31 2021	n/a	n/a	US$1b
Dec 31 2020	US$13m	US$1m	US$2b
Sep 30 2020	n/a	n/a	US$2b
Jun 30 2020	n/a	n/a	US$2b
Mar 31 2020	n/a	n/a	US$2b
Dec 31 2019	US$15m	US$1m	US$2b
Sep 30 2019	n/a	n/a	US$3b
Jun 30 2019	n/a	n/a	US$4b
Mar 31 2019	n/a	n/a	US$4b
Dec 31 2018	US$14m	US$1m	US$4b
Sep 30 2018	n/a	n/a	US$1b
Jun 30 2018	n/a	n/a	US$1b
Mar 31 2018	n/a	n/a	US$1b
Dec 31 2017	US$14m	US$1m	US$1b

Compensación vs. Mercado: La compensación total de Kevin($USD20.77M) está por encima de la media de empresas de tamaño similar en el mercado BR ($USD6.10M).

Compensación vs. Ingresos: La compensación de Kevin ha sido consistente con los resultados de la empresa en el último año.

CEO

Kevin Lobo (59 yo)

11.9yrs

Permanencia

US$20,767,847

Compensación

Mr. Kevin A. Lobo has been the Chief Executive Officer of Stryker Corporation since October 1, 2012 and serves as its President since October 01, 2021. He serves as Chairman of the Board at The Advanced Me...

Equipo directivo

Nombre	Posición	Permanencia	Compensación	Propiedad
Kevin Lobo	Chairman	11.9yrs	US$20.77m	0.026% $ 198.0m
Glenn Boehnlein	VP & CFO	8.4yrs	US$6.84m	0.0012% $ 8.7m
Viju Menon	Group President of Global Quality & Operations	6.4yrs	US$4.47m	0.0024% $ 18.2m
J. Pierce	Group President of MedSurg & Neurotechnology	6.1yrs	US$6.49m	0.015% $ 113.3m
Spencer Stiles	Group President of Orthopaedics & Spine	6.1yrs	US$6.49m	0.014% $ 102.6m
William Berry	VP & Chief Accounting Officer	3.1yrs	sin datos	0.00078% $ 5.9m
Robert Cohen	CTO and VP of Global R&D - Joint Replacement	no data	sin datos	sin datos
Alan Douville	VP, Chief Information Officer & Chief Information Security Officer	6yrs	sin datos	sin datos
Jason Beach	Vice President of Finance & Investor Relations	2.2yrs	sin datos	sin datos
Robert Fletcher	VP & Chief Legal Officer	5.4yrs	US$2.24m	0.0024% $ 18.4m
Dana McMahon	VP & Chief Compliance Officer	no data	sin datos	sin datos
Yin Becker	VP of Communications	5.8yrs	sin datos	0.0082% $ 61.7m

6.0yrs

Permanencia media

57yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de S1YK34 es experimentado (5.8 años antigüedad media).

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Kevin Lobo	Chairman	11.9yrs	US$20.77m	0.026% $ 198.0m
Lisa Skeete Tatum	Independent Director	4.3yrs	US$319.25k	0.00085% $ 6.4m
Howard Cox	Director Emeritus	6.3yrs	US$38.86k	sin datos
John Brown	Chairman Emeritus	no data	US$286.99k	5.26% $ 39.5b
Ronda Stryker	Independent Director	40.7yrs	US$319.25k	4.83% $ 36.2b
Mary Brainerd	Independent Director	7.1yrs	US$334.25k	0.0015% $ 11.5m
Allan Golston	Independent Director	13.7yrs	US$334.25k	0.0039% $ 29.3m
Sherilyn S. McCoy	Lead Independent Director	6.3yrs	US$359.25k	0.00022% $ 1.7m
Rajeev Suri	Independent Director	6.3yrs	US$319.25k	0.0014% $ 10.3m
Giovanni Caforio	Independent Director	3.8yrs	US$319.25k	0.00067% $ 5.0m
Andrew Silvernail	Independent Director	10.8yrs	US$339.25k	0.0015% $ 11.0m
Rachel Ruggeri	Independent Director	less than a year	sin datos	0.000010% $ 75.0k

6.3yrs

Permanencia media

59yo

Promedio de edad

Junta con experiencia: La junta directiva de S1YK34 se considera experimentada (6.1 años de antigüedad promedio).

Stryker Dirección

Dirección controles de criterios 3/4

Información clave

Actualizaciones recientes de la dirección

Stryker Corporation, Annual General Meeting, May 09, 2024

Stryker Corporation Announces Dr. Srikant Datar Will Retire from Board of Directors

Stryker Corporation Announces Board Changes

Stryker Corporation Announces Retirement of Roch Doliveux as Board of Directors

Stryker Corporation Appoints Giovanni Caforio as Director

Recent updates

Stryker Corporation (NYSE:SYK) acquired NICO Corporation.

Stryker Corporation (NYSE:SYK) completed the acquisition of Care.ai inc.

Stryker Corporation (NYSE:SYK) acquired The Osteotomy Truss System (OTS) and Ankle Truss System of 4WEB Inc.

Stryker Corporation (NYSE:SYK) entered into a definitive agreement to acquire Vertos Medical Inc.

Stryker Corporation (NYSE:SYK) agreed to acquire Care.ai inc.

Stryker Announces Launch of Pangea Plating System

Stryker's Spine Guidance 5 Software Featuring Copilot Receives 510(K) Clearance from FDA

Stryker Corporation (NYSE:SYK) completed the acquisition of Artelon, Inc.

Stryker Corporation to Report Q2, 2024 Results on Jul 30, 2024

Stryker Releases Lifepak 35 Monitor/Defibrillator

Stryker Corporation (NYSE:SYK) agreed to acquire Artelon, Inc.

First European Announces That Surgeries Completed Using Stryker’s Gamma4 Hip Fracture Nailing System

Stryker Corporation Provides Earnings Guidance for the Full Year 2024

Stryker Corporation to Report Q1, 2024 Results on Apr 30, 2024

Stryker Launches Gamma4 Hip Fracture Nailing System in Europe

Stryker Announces the Launch of Prophecy Footprint, an Expansion of the Prophecy Surgical Planning System, Offering Comprehensive Surgical Planning Across the Entire Foot

Stryker Corporation Provides Earnings Guidance for the Year 2024

Stryker Corporation (NYSE:SYK) executed a binding offer to acquire Serf from SAS Menix.

Stryker Corporation, Annual General Meeting, May 09, 2024

Stryker Corporation Announces Dr. Srikant Datar Will Retire from Board of Directors

Stryker Corporation Declares Quarterly Dividend, Payable on January 31, 2024

Stryker Corporation Provides Earnings Guidance for the Full Year 2023

Stryker to Showcase Q Guidance System with Spine Guidance Software

Stryker Corporation to Report Q3, 2023 Results on Nov 02, 2023

Stryker Launches PROstep® MIS Lapidus, a New Minimally Invasive Surgical Option for Treating Patients with Bunions

Stryker Corporation Releases Its Next-Generation of Advanced Surgical Cameras

Stryker’S Pangea Systems Receive Food & Drug Administration Clearance

Stryker Corporation Provides Earnings Guidance for the Year 2023

Stryker Corporation to Report Q2, 2023 Results on Aug 03, 2023

Surgeons Successfully Complete First Surgical Cases Using Stryker’s Q Guidance System with Cranial Guidance Software

Stryker Corporation Declares Quarter Dividend, Payable on July 31, 2023

Stryker’s Q Guidance System for Cranial Applications Receives FDA Clearance

Stryker Declares Quarterly Dividend, Payable on April 28, 2023

Stryker Corporation Provides Earnings Guidance for the Year 2023

Stryker Corporation to Report Q4, 2022 Results on Jan 31, 2023

Stryker Launches Citrefix™ Suture Anchor System

Stryker Corporation Declares Quarterly Dividend, Payable January 31, 2023

Stryker Opens the OR of the Future for Customers to Experience Tomorrow's OR

Stryker Corporation Provides Earnings Guidance for the Year 2022

Stryker Corporation Launches Monterey AI Interbody System with New Pre-Clinical Data

Stryker Launches Q Guidance System with Spine Guidance Software

Stryker Receives FDA Clearance for OptaBlate Bone Tumor Ablation System

Stryker Launches Pulse Intelligent Delivery Platform

Stryker Launches New Gamma4 Hip Fracture Nailing System

Stryker Declares Quarterly Dividend, Payable on October 31, 2022

Stryker Corporation Provides Earnings Guidance for the Full Year of 2022

Stryker Corporation to Report Q2, 2022 Results on Jul 26, 2022

Lieff Cabraser & Shavitz Law Group Files Federal Collective and California Class Action Lawsuit Against Stryker Corporation for Failure to Pay Overtime Wages, Provide Meal and Rest Breaks, and Pay Business Expenses

Stryker Receives FDA Clearance for Q Guidance System for Spine Applications

Stryker Corporation Announces Board Changes

Stryker Corporation Declares Quarterly Dividend, Payable July 29, 2022

Stryker Corporation to Report Q1, 2022 Results on Apr 28, 2022

Stryker Launches PROstep™ MICA® SOLO Guide

Stryker Corporation (NYSE:SYK) completed the acquisition of Vocera Communications, Inc. (NYSE:VCRA).

Stryker Declares Quarterly Dividend, Payable April 29, 2022

Stryker Announces New Tornier Perform® Patient-Matched Primary Reversed Glenoid

Stryker Corporation (NYSE:SYK) signed a definitive agreement to acquire Vocera Communications, Inc. (NYSE:VCRA) for $2.9 billion.

Stryker Corporation (NYSE:SYK) acquired Gauss Surgical, Inc.

Stryker Launches T2 Alpha Femur Retrograde Nailing System

Stryker Launches SurgiCount+ Safety-Sponge System

Stryker Introduces Tornier Shoulder Arthroplasty Portfolio and Launches New Tornier Perform Humeral System

Stryker Declares Quarterly Dividend Payable on July 30, 2021

Stryker Corporation Provides Earnings Guidance for the Year of 2021

Critical Care Diagnostics, Inc. acquired T/Pump Product Line from Stryker Corporation (NYSE:SYK).

Stryker Corporation Announces Retirement of Roch Doliveux as Board of Directors

Stryker Corporation Launches Hospital Bed

Stryker Corporation Announces Not to Provide Quarterly Guidance

Stryker Corporation (NYSE:SYK) acquired OrthoSensor, Inc.

Stryker Launches T7™ Personal Protection System

DJO Global, Inc. completed the acquisition of STAR Total Ankle Replacement, Finger Joint Replacement Products and Related Assets from Stryker Corporation (NYSE:SYK).